SONYA FLEMING: Open Payments
NPI 1326750514 · HIGH POINT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 50 payments from 15 companies in 2025. Trend: 2023 $438 · 2024 $1,108 · 2025 $1,006
Food & beverage: $1,006
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $411 |
| Novo Nordisk Inc | 4 | $210 |
| Viatris Specialty LLC | 2 | $45 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $43 |
| Lilly USA, LLC | 2 | $42 |
| Gilead Sciences, Inc. | 2 | $37 |
| Aimmune Therapeutics, Inc. | 2 | $33 |
| Corcept Therapeutics | 1 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| HARMONY BIOSCIENCES LLC | 1 | $25 |
Products named: QULIPTA, Wegovy, VRAYLAR, Ozempic, UBRELVY, YUPELRI, JOURNAVX, ZENPEP.
Industry payments across NC — which companies pay providers there.
